Medicine & Life Sciences
Breast Neoplasms
100%
Triple Negative Breast Neoplasms
88%
Fibroblast Growth Factor Receptors
84%
Neoplasms
78%
Mitogen-Activated Protein Kinase Kinases
74%
AZD8186
73%
Alternative Splicing
70%
Heterografts
66%
Mitogen-Activated Protein Kinases
64%
selinexor
60%
N-(4-(3-chloro-4-(2-pyridinylmethoxy)anilino)-3-cyano-7-ethoxy-6-quinolyl)-4-(dimethylamino)-2-butenamide
56%
sacituzumab govitecan
50%
Drug Therapy
44%
Immunoconjugates
43%
Decitabine
42%
Cell Line
41%
Trastuzumab
38%
Paclitaxel
38%
Cholangiocarcinoma
37%
In Vitro Techniques
36%
Oxidative Phosphorylation
36%
Combination Drug Therapy
36%
Protein Array Analysis
33%
Thyroid Neoplasms
33%
Phosphatidylinositol 3-Kinases
32%
palbociclib
30%
Topoisomerase I Inhibitors
28%
Immunotherapy
28%
Actins
27%
eribulin
27%
Growth
26%
Colorectal Neoplasms
25%
Therapeutics
23%
Hormones
22%
AZD 6244
21%
Up-Regulation
17%
trametinib
16%
Mutation
16%
Progression-Free Survival
15%
4,17 beta-dihydroxy-4-androstene-3-one
14%
Cyclin E
13%
Everolimus
13%
Immunohistochemistry
13%
cabozantinib
13%
Cell Proliferation
12%
Tumor Burden
12%
Immunoblotting
11%
Proto-Oncogene Proteins c-mdm2
10%
Mitochondrial Genes
10%